Ativo Capital Management LLC Sells 2,700 Shares of Danaher Corporation (DHR)
Ativo Capital Management LLC reduced its stake in Danaher Corporation (NYSE:DHR) by 9.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,292 shares of the conglomerate’s stock after selling 2,700 shares during the period. Ativo Capital Management LLC’s holdings in Danaher Corporation were worth $2,134,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Rafferty Asset Management LLC acquired a new stake in Danaher Corporation in the 2nd quarter valued at $803,000. Mutual of America Capital Management LLC increased its holdings in Danaher Corporation by 0.5% in the 2nd quarter. Mutual of America Capital Management LLC now owns 74,412 shares of the conglomerate’s stock valued at $6,280,000 after purchasing an additional 385 shares in the last quarter. Acrospire Investment Management LLC increased its holdings in Danaher Corporation by 185.5% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock valued at $143,000 after purchasing an additional 1,100 shares in the last quarter. Investec Asset Management PTY Ltd increased its holdings in Danaher Corporation by 51.5% in the 2nd quarter. Investec Asset Management PTY Ltd now owns 18,406 shares of the conglomerate’s stock valued at $1,550,000 after purchasing an additional 6,254 shares in the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in Danaher Corporation by 0.9% in the 2nd quarter. PNC Financial Services Group Inc. now owns 294,026 shares of the conglomerate’s stock valued at $24,812,000 after purchasing an additional 2,611 shares in the last quarter. Hedge funds and other institutional investors own 75.66% of the company’s stock.
Danaher Corporation (NYSE:DHR) opened at 90.79 on Friday. The company has a market cap of $63.07 billion, a PE ratio of 28.98 and a beta of 1.03. Danaher Corporation has a 12 month low of $76.27 and a 12 month high of $91.64. The stock’s 50 day moving average is $86.59 and its 200 day moving average is $84.29.
Danaher Corporation (NYSE:DHR) last posted its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.05. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.48%. The company had revenue of $4.53 billion for the quarter, compared to the consensus estimate of $4.47 billion. During the same quarter in the previous year, the firm posted $0.87 EPS. The business’s revenue was up 9.6% compared to the same quarter last year. Equities analysts predict that Danaher Corporation will post $3.97 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be issued a dividend of $0.14 per share. The ex-dividend date is Thursday, September 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.62%. Danaher Corporation’s payout ratio is 16.52%.
DHR has been the subject of several recent research reports. J P Morgan Chase & Co reiterated an “overweight” rating and issued a $95.00 price target on shares of Danaher Corporation in a report on Friday, September 8th. BidaskClub downgraded Danaher Corporation from a “hold” rating to a “sell” rating in a report on Saturday, July 8th. Wells Fargo & Company reiterated a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Citigroup Inc. set a $96.00 price target on Danaher Corporation and gave the company a “buy” rating in a report on Friday, July 21st. Finally, Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 target price for the company in a research note on Thursday, October 5th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Danaher Corporation presently has a consensus rating of “Buy” and a consensus target price of $93.31.
In other news, insider William King sold 43,688 shares of the business’s stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the transaction, the insider now owns 45,748 shares in the company, valued at approximately $3,790,679.28. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the transaction, the insider now owns 155,520 shares in the company, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. Insiders own 12.20% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://www.watchlistnews.com/ativo-capital-management-llc-sells-2700-shares-of-danaher-corporation-dhr/1645134.html.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.